NEW YORK, Nov. 14, 2022 /PRNewswire/ -- The global spatial genomics and transcriptomics market size is expected to grow by USD 401.47 million, accelerating at a CAGR of 9.06% between 2021 and 2026. The market has been categorized as a part of the global life science tools and services market. The parent, global life science tools and services market covers products and companies engaged in R&D of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for R&D on pharmaceuticals and biotechnology products and laboratory diagnosis of various diseases. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Get more highlights into the parent market. Download a Free PDF Sample Report
Spatial Genomics and Transcriptomics Market 2022-2026: Scope
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The spatial genomics and transcriptomics market report covers the following areas:
- Spatial Genomics and Transcriptomics Market Size
- Spatial Genomics and Transcriptomics Market Trends
- Spatial Genomics and Transcriptomics Market Industry Analysis
Technavio's library includes over 17,000+ reports covering more than 2,000 emerging
technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to
our Technavio Insights
Spatial Genomics and Transcriptomics Market 2022-2026: Vendor Landscape
The global spatial genomics and transcriptomics market is fragmented due to the presence of several local, regional, and global vendors. The market is dominated by vendors such as NanoString Technologies, Inc., 10x Genomics, Inc., S2 Genomics, Inc., and Dovetail Genomics LLC. The competition consists of vertically integrated companies and small vendors and startups, which are backed by venture capital funding. The intense competition has encouraged established vendors to extend their geographical reach and presence by expanding their production facilities and focusing on product development and innovation. The presence of similar offerings and the increasing number of vendors and startups lead to price wars and reduce the profitability of vendors. Vendors compete on factors such as reliability, superior quality, R&D, timeliness of service, and service optimization. The intense competition and evolving end-user preferences will compel vendors to focus on product development, which will improve the functionality of spatial genomics and transcriptomics techniques.
Gain deeper insights into the vendor landscape and make informed business decisions.
Buy Report Now!
Spatial Genomics and Transcriptomics Market 2022-2026: Segmentation
The global spatial genomics and transcriptomics market is segmented as below:
- Product
- Instruments
- Consumables
The market growth in the instruments segment will be significant over the forecast period. The growth of the segment is driven by the increasing use of instruments in applications such as sequencing platforms, immunohistochemistry (IHC), microscopy, flow cytometry, and mass spectrometry devices and tools.
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
39% of the market growth will come from North America during the forecast period. The growth of the spatial genomics and transcriptomics market in North America is majorly attributed to the presence of a large number of laboratories, research facilities, and pharmaceutical companies. Spatial genomics and transcriptomics find extensive application in North American countries, such as the US and Canada. Identify other key segments and regions in the market. Download a Free Sample Report
Spatial Genomics and Transcriptomics Market 2022-2026: Key Highlights
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist spatial genomics and transcriptomics market growth during the next five years
- Estimation of the spatial genomics and transcriptomics market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the spatial genomics and transcriptomics market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of spatial genomics and transcriptomics market vendors
Related Reports
- The genomics market share is expected to increase by USD 14.50 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 10.36%. The rising investments in genomic research and development are notably driving the genomics market growth, although factors such as varying regulations in genomic research and testing may impede the market growth.
- The pharmacogenomics market share is expected to increase by USD 2.50 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.93%. The rising prevalence of genetic diseases and disorders is notably driving the pharmacogenomics market growth, although factors such as varying regulations on pharmacogenomics testing and research globally may impede the market growth.
Spatial Genomics and Transcriptomics Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.06% |
Market growth 2022-2026 |
USD 401.47 million |
Market structure |
Fragmented |
YoY growth (%) |
6.44 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Australia, Austria, Switzerland, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
10X Genomics Inc., Akoya Biosciences Inc., Bio Rad Laboratories Inc., BioSpyder Technologies Inc., Bio Techne Corp., Dovetail Genomics LLC, Fluidigm Corp., Illumina Inc., Lunaphore Technologies SA, NanoString Technologies Inc., PerkinElmer Inc., RareCyte Inc, Rebus Biosystems Inc, Resolve BioSciences GmbH, S2 Genomic Inc, Seven Bridges Genomics Inc., Singular Genomics System Inc, Ultivue Inc., Veranome Biosystems LLC, and Vizgen Corp |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Instruments - Market size and forecast 2021-2026
- Exhibit 28: Chart on Instruments - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Instruments - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Instruments - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Instruments - Year-over-year growth 2021-2026 (%)
- 5.4 Consumables - Market size and forecast 2021-2026
- Exhibit 32: Chart on Consumables - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Consumables - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Consumables - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Consumables - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Product
- Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Austria - Market size and forecast 2021-2026
- Exhibit 62: Chart on Austria - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Austria - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Austria - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Austria - Year-over-year growth 2021-2026 (%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.10 Switzerland - Market size and forecast 2021-2026
- Exhibit 70: Chart on Switzerland - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Switzerland - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Switzerland - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Switzerland - Year-over-year growth 2021-2026 (%)
- 7.11 Australia - Market size and forecast 2021-2026
- Exhibit 74: Chart on Australia - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Australia - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Australia - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 10X Genomics Inc.
- Exhibit 85: 10X Genomics Inc. - Overview
- Exhibit 86: 10X Genomics Inc. - Product / Service
- Exhibit 87: 10X Genomics Inc. - Key offerings
- 10.4 Akoya Biosciences Inc.
- Exhibit 88: Akoya Biosciences Inc. - Overview
- Exhibit 89: Akoya Biosciences Inc. - Product / Service
- Exhibit 90: Akoya Biosciences Inc. - Key offerings
- 10.5 Bio Rad Laboratories Inc.
- Exhibit 91: Bio Rad Laboratories Inc. - Overview
- Exhibit 92: Bio Rad Laboratories Inc. - Business segments
- Exhibit 93: Bio Rad Laboratories Inc. - Key news
- Exhibit 94: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 95: Bio Rad Laboratories Inc. - Segment focus
- 10.6 Bio Techne Corp.
- Exhibit 96: Bio Techne Corp. - Overview
- Exhibit 97: Bio Techne Corp. - Business segments
- Exhibit 98: Bio Techne Corp. - Key news
- Exhibit 99: Bio Techne Corp. - Key offerings
- Exhibit 100: Bio Techne Corp. - Segment focus
- 10.7 Illumina Inc.
- Exhibit 101: Illumina Inc. - Overview
- Exhibit 102: Illumina Inc. - Business segments
- Exhibit 103: Illumina Inc. - Key news
- Exhibit 104: Illumina Inc. - Key offerings
- Exhibit 105: Illumina Inc. - Segment focus
- 10.8 Lunaphore Technologies SA
- Exhibit 106: Lunaphore Technologies SA - Overview
- Exhibit 107: Lunaphore Technologies SA - Product / Service
- Exhibit 108: Lunaphore Technologies SA - Key offerings
- 10.9 NanoString Technologies Inc.
- Exhibit 109: NanoString Technologies Inc. - Overview
- Exhibit 110: NanoString Technologies Inc. - Product / Service
- Exhibit 111: NanoString Technologies Inc. - Key offerings
- 10.10 PerkinElmer Inc.
- Exhibit 112: PerkinElmer Inc. - Overview
- Exhibit 113: PerkinElmer Inc. - Business segments
- Exhibit 114: PerkinElmer Inc. - Key news
- Exhibit 115: PerkinElmer Inc. - Key offerings
- Exhibit 116: PerkinElmer Inc. - Segment focus
- 10.11 Rebus Biosystems Inc
- Exhibit 117: Rebus Biosystems Inc - Overview
- Exhibit 118: Rebus Biosystems Inc - Key offerings
- 10.12 S2 Genomic Inc
- Exhibit 119: S2 Genomic Inc - Overview
- Exhibit 120: S2 Genomic Inc - Product / Service
- Exhibit 121: S2 Genomic Inc - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 122: Inclusions checklist
- Exhibit 123: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 124: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 125: Research methodology
- Exhibit 126: Validation techniques employed for market sizing
- Exhibit 127: Information sources
- 11.5 List of abbreviations
- Exhibit 128: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article